Fibronostics USA, Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. (NCT04579874) | Fibronostics USA, Inc | 2021-01-07 |
| Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy (NCT03980912) | Fibronostics USA, Inc | 2019-09-01 |
Track Fibronostics USA, Inc automatically
Every clearance here is in the API, with alerts when new ones post.